Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

Introduction: Minimally invasive extracorporeal circulation (MiECC) reduced inflammatory burden, leading to best clinical outcomes in patients treated with coronary artery bypass grafting (CABG). Despite this, the patients with type 2 diabetes mellitus (T2DM) vs those without T2DM (non-T2DM) have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardu, Celestino, Massetti, Massimo, Testa, Nicola, Martino, Luigi Di, Castellano, Gaetano, Turriziani, Fabrizio, Sasso, Ferdinando Carlo, Torella, Michele, De Feo, Marisa, Santulli, Gaetano, Paolisso, Giuseppe, Marfella, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634684/
https://www.ncbi.nlm.nih.gov/pubmed/34867407
http://dx.doi.org/10.3389/fphar.2021.777083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634684/
https://www.ncbi.nlm.nih.gov/pubmed/34867407
http://dx.doi.org/10.3389/fphar.2021.777083

Ejemplares similares